Spontaneous Intracranial Hypotension (SIH) is a troubling neurological disorder caused by cerebrospinal fluid (CSF) leakage, leading to a reduction in intracranial pressure and resulting in severe posture-related headaches. The most common treatment is the epidural blood patch (EBP), where the patient’s own blood is injected into the epidural space to seal the leak. However, a key challenge in this procedure is ensuring that the drawn blood remains in a liquid state without the use of anticoagulants, allowing it to clot quickly after injection to effectively stop the leak.
Traditionally, medical staff manually shake the blood in a tube to delay coagulation. However, this method is time-consuming, labor-intensive, and difficult to control, with an increased risk of premature coagulation. If the blood clots too early, it can compromise the success of the treatment, leaving patients to suffer from persistent headaches.
Technological Innovation: The Physical Anticoagulation Device
To overcome the limitations of the traditional method, Lung-Hui Chiang and his radiology team at Tri-Service General Hospital developed an innovative external physical anticoagulation device. The idea was inspired by shaking mechanisms in mobile games. Through precise mechanical design and electronic control, the device can shake the blood tube at a constant speed and amplitude, ensuring the blood remains fluid outside the body. Compared to manual shaking, this mechanical method provides more stable and uniform force, significantly reducing the risk of coagulation and improving treatment efficiency. Medical staff simply place the blood in the device, which then shakes it automatically, eliminating the need for manual operation.
Clinical trials have confirmed that using this external physical anticoagulation device for the EBP procedure significantly improves treatment success rates and reduces side effects. This innovation offers new hope to patients with SIH and presents a potential solution for other medical procedures requiring anticoagulation.
Future Outlook and Clinical Applications
Lung-Hui Chiang emphasized that the research team will continue to optimize the device, making it more functional and applicable in a broader range of medical scenarios. For instance, they aim to develop smaller, portable versions of the device for use in various medical settings. Additionally, the technology could be applied to other procedures that require anticoagulation, such as blood dialysis and cancer treatments.
The team is also dedicated to promoting the clinical application of the external physical anticoagulation device. By collaborating with medical device manufacturers, they plan to accelerate mass production and commercialization, ensuring that more patients can benefit from this innovative technology.
Resource (mandarin): 手遊給靈感救自發性低腦壓頭痛 機器搖晃試管防凝血！
